4Gianni L,Kearans CM,Gianni A et al.Nonliners pharmacokineyics and its pharmacokinetic pharmacodynamic relationships in humans.L Clin Oncol,1995,13:180～190
5Ozols RF,YongRC.Chemotherapy of ovarian canaer.Semin Oncol,1991,18:222～224
6Aravantions G,Skarlos DV,Kosmidis P et al.A phase Ⅱ study of paclitaxel in platinum pretre ated ovarian cancer.Eur J Cancer,1997,33:160 ～ 163
7Mcquire WP,Hoskins WJ,Brady MF et al.Cyclophosphamide and cisplatin in patients with stage Ⅲ and Ⅳ ovarian cancer.N engl J Med,1996,334:1 ～6
8Siddiqui N,Boddy AV,Thomas HD et al.A clinical and pharmacokinetic study of the combination of carboplation and paclitaxel for epithelial ovarian cancer.Br J Cancer,1997,75:287 ～ 297
4Ozols RF, Yonn RC. Chemotherapy of ovarian cancer [ J ]. Sem Oncol, 1991,18 : 222.
5Tommy K, Ingrid K, Per N, et al. Volumetric and dosime - tric evaluation ofradiation treatment planning: radiation conformily index [ J ]. Int J Radial Oncol Biol Phys, 1998,42 ( 5 ) : 1169.
6Siddiqui N, Boddy AV ,Thorn as HD, et al. A clinical and phamacoki - netie study of the earboplation and paclitaxel for epidieli - al ovariancer[ J ]. BrJ Cancer, 1997, 75:287 - 297.
